慢性病管理：治疗药物、设备技术与全球市场

全球慢性病管理药物和器械技术市场规模将从 2023 年的 6,750 亿美元成长到 2024 年的 7,263 亿美元，预测期内复合年增长率为 8.1%，到 2029 年将成长到 1.1 兆美元。美元。

製药和生技药品产业预计将从 2024 年的 5,135 亿美元成长到 2029 年的 7,540 亿美元，复合年增长率为 8.0%。此外，数位治疗产业预计将从 2024 年的 646 亿美元成长到 2029 年的 1,117 亿美元，复合年增长率为 11.6%。

该报告调查了全球慢性病管理市场，并提供市场概况、市场影响因素和市场机会分析、法律制度、新兴技术和技术发展趋势、市场规模趋势和预测、各个细分市场和地区。格局、主要企业概况等。

目录

第一章执行摘要

• 市场展望
• 调查范围
• 最新资讯
• 市场概况

第二章 市场概况

• 市场分析
• 监理背景
• Chronic Disease Management Act of 2021 (CDMA)
• 慢性病医疗设备法律规范：按地区
• 药品监理体系：按地区
• 定价和报销背景
• 医疗设备定价和报销：按地区
• 药品定价和报销：按地区

第三章市场动态

• 概述
• 市场驱动因素
• 世界老化
• 慢性病增加
• 技术进步
• 政府措施和资金
• 市场限制因素
• 治疗费用上涨
• 专利到期和产品生命週期缩短
• 与药品、医疗设备和软体应用相关的监管问题
• 低收入地区的准入限制
• 市场挑战
• 不遵守药物治疗
• 监管挑战
• 数位健康应用的挑战
• 市场机会
• 数位疗法
• 主要企业的强大研发倡议

第四章市场区隔分析

• 细分细分
• 市场分析：依产品类型
• 药品和生技药品
• 医疗设备
• 数位疗法
• 市场分析：依应用分类
• 肿瘤性疾病
• 代谢紊乱
• 心血管疾病
• 免疫疾病
• 呼吸系统疾病
• 肌肉骨骼疾病
• 慢性胃肠道疾病
• 神经系统疾病
• 精神疾病
• 其他的
• 市场分析：按最终用户
• 居家照护
• 医院等
• 地域分布
• 市场分析：按地区
• 北美洲
• 欧洲
• 亚太地区
• 其他领域

第五章 新趋势与新技术

• 概述
• 行动医疗技术
• 慢性病管理中的人工智慧、机器学习和深度学习
• 远端患者监护装置
• 数位疗法
• 生物穿戴技术
• 葡萄糖感测器隐形眼镜
• 近期新药和医疗设备的核准和上市

第六章 ESG趋势

• ESG在慢病管理产业的应用
• ESG风险评估
• BCC 研究的观点

第七章 竞争格局

• 併购/合作
• 专利分析
• 专利审查：按受让人国家/地区
• 专利审查：按年份
• 企业市场占有率分析
• 策略联盟

第8章附录

• 调查方法
• 来源
• 简称
• 公司简介
• ABBOTT
• AMGEN INC.
• ASTRAZENECA
• BOSTON SCIENTIFIC CORP.
• BRISTOL-MYERS SQUIBB CO.
• F. HOFFMANN-LA ROCHE LTD.
• GSK PLC.
• JOHNSON & JOHNSON SERVICES INC.
• MEDTRONIC
• PFIZER INC.

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

The global market for pharmaceutical drugs and biologics for chronic disease management is projected to grow from $513.5 billion in 2024 to $754.0 billion by 2029, at a CAGR of 8.0% from 2024 through 2029.

The global market for digital therapeutics for chronic disease management is projected to grow from $64.6 billion in 2024 to $111.7 billion by 2029, at a CAGR of 11.6% from 2024 through 2029.

Report Scope

Chronic disease management encompasses drugs and medical device-based techniques. This report can serve as an analytical business tool to evaluate the global market for therapeutics and advanced device technologies for chronic disease management.

This report analyzes market trends with data from 2023, estimates for 2024 and projections of CAGRs through 2029. It evaluates the market potential for chronic disease management and provides an analysis of the competitive landscape. The report covers the market's drivers, restraints and opportunities, as well as the market shares of leading companies.

The market is segmented into product type, application, end user, and geographic region. Product segments include pharmaceuticals and biologics (drugs and biologics), medical devices (traditional and wearable devices) and digital therapeutics. Application areas (disease categories) are cancer, metabolic disorders, musculoskeletal disorders, cardiovascular conditions, immunological disorders, gastrointestinal disorders, respiratory diseases, neurological conditions, psychiatric conditions, and others. End users are categorized into hospitals and other facilities and home care. The global market is segmented into the regions of North America, Europe, Asia-Pacific, and the Rest of the World (RoW). This analysis also includes broken down by country.

Report Includes

• 106 data tables and 39 additional tables
• Analyses of global market trends, with historic market revenue data (sales figures) from 2021 to 2022, estimates for 2023, forecast for 2024, and projected CAGRs through 2029
• Estimates of the current market size and revenue prospects of the global market, along with a market share analysis by product type, application, end user, and region
• Analysis of the market dynamics, technological advances, regulations, and the macroeconomic factors influencing the market
• A look into the current state of chronic diseases and disorders, with an emphasis on advance needle-free drug delivery technologies, diagnostic methods, and smart device technologies that support chronic disease management
• Identification of promising new drugs, biologics, and emerging device technologies still in the development and testing stages
• A look at the regulatory structure for pharmaceuticals and medical devices, pricing and reimbursement structure, marketed and pipeline products and their potential for commercialization
• A look at the recent patent grants
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices of leading companies
• Analysis of the industry structure, including company market shares, strategic alliances, M&A activity and a venture funding outlook
• Profiles of market leaders, including Abbott, Bristol Myers Squibb Co., F. Hoffmann-La Roche Ltd., Pfizer Inc., and Johnson & Johnson Services Inc.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• What's New in This Update?
• Market Summary

Chapter 2 Market Overview

• Market Insights
• Regulatory Background
• Chronic Disease Management Act of 2021 (CDMA)
• Regional Regulatory Frameworks for Chronic Disease Medical Devices
• Regulatory Systems for Pharmaceuticals, by Region
• Pricing and Reimbursement Background
• Pricing and Reimbursement for Medical Devices, by Region
• Pricing and Reimbursement for Pharmaceuticals, by Region

Chapter 3 Market Dynamics

• Overview
• Market Drivers
• Growing Aging Population Worldwide
• Growing Prevalence of Chronic Diseases
• Technological Advances
• Government Initiatives and Funding
• Market Restraints
• High Cost of Treatments
• Patent Expiry and Shorter Product Life Cycles
• Regulatory Issues for Drugs, Medical Devices and Software Applications
• Limited Access in Low-Income Regions
• Market Challenges
• Medication Nonadherence
• Regulatory Challenges
• Challenges with Digital Health Applications
• Market Opportunities
• Digital Therapeutics
• Strong Research and Development Initiatives from Key Market Players

Chapter 4 Market Segmentation Analysis

• Segmentation Breakdown
• Market Analysis, by Product Type
• Pharmaceutical Drugs and Biologics
• Medical Devices
• Digital Therapeutics
• Market Analysis, by Application
• Oncological Diseases
• Metabolic Disorders
• Cardiovascular Diseases
• Immunological Disorders
• Respiratory Diseases
• Musculoskeletal Disorders
• Chronic Gastrointestinal Diseases
• Neurological Diseases
• Psychiatric Disorders
• Other Applications
• Market Analysis, by End User
• Home Care
• Hospitals and Others
• Geographic Breakdown
• Market Analysis, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 5 Emerging Trends and Technologies

• Overview
• Mobile Health Technology
• AI, Machine Learning, and Deep Learning in Chronic Care Management
• Remote Patient Monitoring Devices
• Digital Therapeutics
• Biowearable Technology
• Glucose-Sensing Contact Lenses
• Recent Approvals and Launches of Novel Drug and Device Products

Chapter 6 ESG Developments

• ESG in the Chronic Disease Management Industry
• ESG Risk Ratings
• BCC Research Viewpoint

Chapter 7 Competitive Landscape

• Mergers, Acquisitions and Collaborations
• Patent Analysis
• Patent Review, by Assignee Country
• Patent Review, by Year
• Company Share Analysis
• Strategic Alliances

Chapter 8 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• ABBOTT
• AMGEN INC.
• ASTRAZENECA
• BOSTON SCIENTIFIC CORP.
• BRISTOL-MYERS SQUIBB CO.
• F. HOFFMANN-LA ROCHE LTD.
• GSK PLC.
• JOHNSON & JOHNSON SERVICES INC.
• MEDTRONIC
• PFIZER INC.

List of Tables

• Summary Table : Global Market for Chronic Disease Management, Therapeutics and Device Technologies, by Product Type, Through 2029
• Table 1 : People 65 Years and Over, by Development Group, 2023 and 2050
• Table 2 : People 65 Years or Over, by WHO Region, 2019 and 2050
• Table 3 : Projected Number of U.S. Adults 50 and Older with More than One Chronic Condition
• Table 4 : Recent EU-Level Initiatives Addressing Chronic Diseases, 2022
• Table 5 : Weighted Adherence Rates in India, 2022
• Table 6 : Global Market for Therapeutics and Device Technologies for Chronic Disease Management, by Product Type, Through 2029
• Table 7 : Global Market for Pharmaceutical Drugs and Biologics for Chronic Disease Management, by Region, Through 2029
• Table 8 : Global Market for Pharmaceutical Drugs and Biologics for Chronic Diseases Management, by Product, Through 2029
• Table 9 : Recently Approved Pharmaceutical Drugs for Chronic Disease Management, 2024
• Table 10 : Global Market for Pharmaceutical Drugs in Chronic Disease Management, by Region, Through 2029
• Table 11 : Recently Approved Biologics for Chronic Disease Management, 2024
• Table 12 : Global Market for Biologics in Chronic Disease Management, by Region, Through 2029
• Table 13 : Global Market for Medical Devices for Chronic Disease Management, by Region, Through 2029
• Table 14 : Global Market for Medical Devices for Chronic Disease Management, by Product Type, Through 2029
• Table 15 : Global Market for Traditional Medical Devices for Chronic Disease Management, by Region, Through 2029
• Table 16 : Global Market for Wearable Medical Devices for Chronic Disease Management, by Region, Through 2029
• Table 17 : Global Market for Digital Therapeutics for Chronic Disease Management, by Region, Through 2029
• Table 18 : Global Market for Therapeutics and Device Technologies for Chronic Disease Management, by Application, Through 2029
• Table 19 : Cancer Deaths in the U.S., 2024
• Table 20 : Global Market for Oncology Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
• Table 21 : Global Market for Metabolic Disorder Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
• Table 22 : Global Market for Cardiovascular Disease Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
• Table 23 : Global Market for Immunological Disorder Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
• Table 24 : Global Market for Respiratory Disease Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
• Table 25 : Global and Regional Key Findings on Rehabilitation Needs, 2021
• Table 26 : Global Market for Musculoskeletal Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
• Table 27 : Global Market for GI Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
• Table 28 : Global Market for Neurological Disorder Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
• Table 29 : Global Market for Psychiatric Diseases Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
• Table 30 : Global Market for Other Disease Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
• Table 31 : Global Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
• Table 32 : Global Market for Home Care Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
• Table 33 : Global Market for Therapeutics and Device Technologies in Hospitals and Other Facilities in Chronic Disease Management, by Region, Through 2029
• Table 34 : Global Market for Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
• Table 35 : North American Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
• Table 36 : North American Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
• Table 37 : North American Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
• Table 38 : North American Market for Therapeutics and Device Technologies in Chronic Disease Management, by Country, Through 2029
• Table 39 : U.S. Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
• Table 40 : U.S. Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
• Table 41 : U.S. Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
• Table 42 : Canada Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
• Table 43 : Canada Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
• Table 44 : Canadian Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
• Table 45 : Mexican Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
• Table 46 : Mexican Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
• Table 47 : Mexican Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
• Table 48 : European Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
• Table 49 : European Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
• Table 50 : European Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
• Table 51 : European Market for Therapeutics and Device Technologies in Chronic Disease Management, by Country, Through 2029
• Table 52 : U.K. Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
• Table 53 : U.K. Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
• Table 54 : U.K. Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
• Table 55 : French Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
• Table 56 : French Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
• Table 57 : French Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
• Table 58 : Italian Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
• Table 59 : Italian Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
• Table 60 : Italian Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
• Table 61 : Leading Causes of Disease Burden in Germany, by DALYs (Level 3), 2022
• Table 62 : German Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
• Table 63 : German Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
• Table 64 : German Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
• Table 65 : Spanish Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
• Table 66 : Spanish Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
• Table 67 : Spanish Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
• Table 68 : Rest of European Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
• Table 69 : Rest of European Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
• Table 70 : Rest of European Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
• Table 71 : Percentage of Healthcare Professionals who Use Digital Health Technology or Mobile Health Apps, by Country, 2021
• Table 72 : Asia-Pacific Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
• Table 73 : Asia-Pacific Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
• Table 74 : Asia-Pacific Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
• Table 75 : Asia-Pacific Market for Therapeutics and Device Technologies in Chronic Disease Management, by Country, Through 2029
• Table 76 : Chinese Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
• Table 77 : Chinese Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
• Table 78 : Chinese Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
• Table 79 : Indian Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
• Table 80 : Indian Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
• Table 81 : Indian Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
• Table 82 : Japanese Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
• Table 83 : Japanese Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
• Table 84 : Japanese Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
• Table 85 : Australian Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
• Table 86 : Australian Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
• Table 87 : Australian Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
• Table 88 : South Korean Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
• Table 89 : South Korean Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
• Table 90 : South Korean Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
• Table 91 : Rest of Asia-Pacific Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
• Table 92 : Rest of Asia-Pacific Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
• Table 93 : Rest of Asia-Pacific Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
• Table 94 : RoW Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product Through 2029
• Table 95 : RoW Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
• Table 96 : RoW Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
• Table 97 : AI-driven Drug Discovery and Development in Cardiology
• Table 98 : ESG Highlights, by Leading Companies, 2023
• Table 99 : ESG Risk Ratings for Pharma Firms in the Chronic Disease Management Market, 2023
• Table 100 : M&A in the Chronic Disease Management Industry, 2021-2024
• Table 101 : Patent Analysis, by Year, 2021-August 2024
• Table 102 : Strategic Alliances in the Chronic Disease Management, Therapeutics and Device Technologies Market, 2021-2024
• Table 103 : Information Sources in This Report
• Table 104 : Abbreviations Used in This Report
• Table 105 : Abbott: Company Snapshot
• Table 106 : Abbott: Financial Performance, FY 2022 and 2023
• Table 107 : Abbott: Product Portfolio
• Table 108 : Abbott: News/Key Developments, 2023 and 2024
• Table 109 : Amgen Inc.: Company Snapshot
• Table 110 : Amgen Inc.: Financial Performance, FY 2022 and 2023
• Table 111 : Amgen Inc.: Product Portfolio
• Table 112 : Amgen Inc.: News/Key Developments, 2021-2024
• Table 113 : AstraZeneca: Company Snapshot
• Table 114 : AstraZeneca: Financial Performance, FY 2022 and 2023
• Table 115 : AstraZeneca: Product Portfolio
• Table 116 : AstraZeneca: News/Key Developments, 2021-2024
• Table 117 : Boston Scientific Corp.: Company Snapshot
• Table 118 : Boston Scientific Corp.: Financial Performance, FY 2022 and 2023
• Table 119 : Boston Scientific Corp.: Products Portfolio
• Table 120 : Boston Scientific Corp.: News/Key Developments, 2023 and 2024
• Table 121 : Bristol-Myers Squibb Co.: Company Snapshot
• Table 122 : Bristol-Myers Squibb Co.: Financial Performance, FY 2022 and 2023
• Table 123 : Bristol-Myers Squibb Co.: Product Portfolio
• Table 124 : Bristol-Myers Squibb Co.: News/Key Developments, 2021-2024
• Table 125 : F. Hoffmann-La Roche Ltd.: Company Snapshot
• Table 126 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
• Table 127 : F. Hoffmann-La Roche Ltd.: Product Portfolio
• Table 128 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2021-2024
• Table 129 : GSK Plc.: Company Snapshot
• Table 130 : GSK Plc.: Financial Performance, FY 2022 and 2023
• Table 131 : GSK Plc.: Product Portfolio
• Table 132 : GSK Plc.: News/Key Developments, 2024
• Table 133 : Johnson & Johnson Services Inc.: Company Snapshot
• Table 134 : Johnson & Johnson Services Inc.: Financial Performance, FY 2022 and 2023
• Table 135 : Johnson & Johnson Services Inc.: Product Portfolio
• Table 136 : Johnson & Johnson Services Inc.: News/Key Developments, 2022-2024
• Table 137 : Medtronic: Company Snapshot
• Table 138 : Medtronic: Financial Performance, FY 2022 and 2023
• Table 139 : Medtronic: Product Portfolio
• Table 140 : Medtronic: News/Key Developments, 2022-2024
• Table 141 : Pfizer Inc.: Company Snapshot
• Table 142 : Pfizer Inc.: Financial Performance, FY 2022 and 2023
• Table 143 : Pfizer Inc.: Product Portfolio
• Table 144 : Pfizer Inc.: News/Key Developments, 2022-2024

List of Figures

• Summary Figure : Global Market for Chronic Disease Management, Therapeutics and Device Technologies, by Product Type, 2021-2029
• Figure 1 : Use of Digital Technologies and Data in Patients' Medicines
• Figure 2 : Comparison of Drug Approval Processes in the U.S. and EU
• Figure 3 : Market Dynamics for Therapeutics and Devices for Chronic Disease Management
• Figure 4 : Share of New Global Cases of Cancer, by Region, 2022
• Figure 5 : Share of Global Cancer Mortality Cases, by Region, 2022
• Figure 6 : Frequency of Non-adherence Behaviors, 2020
• Figure 7 : Global Market Share of Therapeutics and Device Technologies for Chronic Disease Management, by Product Type, 2023
• Figure 8 : Global Market Share of Therapeutics and Device Technologies in Chronic Disease Management, by End User, 2023
• Figure 9 : Global Market for Therapeutics and Device Technologies in Chronic Disease Management, by Region, 2021-2029
• Figure 10 : Global Market Share of Therapeutics and Device Technologies in Chronic Disease Management, by Region, 2023
• Figure 11 : Role of AI in Anti-Cancer Drug Development
• Figure 12 : 2024 Progress Assessment: Tracking Sustainable Development Goals
• Figure 13 : Share of Patents Published on Chronic Disease Management, by Assignee Country, 2021-2024
• Figure 14 : Global Market Shares of Chronic Disease Management, Therapeutics and Device Technologies, by Leading Companies, 2023
• Figure 15 : Abbott: Revenue Share, by Country/Region, FY 2023
• Figure 16 : Abbott: Revenue Share, by Business Unit, FY 2023
• Figure 17 : Amgen Inc.: Revenue Share, by Country/Region, FY 2023
• Figure 18 : Amgen Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 19 : AstraZeneca: Revenue Share, by Country/Region, FY 2023
• Figure 20 : AstraZeneca: Revenue Share, by Business Unit, FY 2023
• Figure 21 : Boston Scientific Corp.: Revenue Share, by Country/Region, FY 2023
• Figure 22 : Boston Scientific Corp.: Revenue Share, by Business Unit, FY 2023
• Figure 23 : Bristol-Myers Squibb Co.: Revenue Share, by Country/Region, FY 2023
• Figure 24 : Bristol-Myers Squibb Co.: Revenue Share, by Business Unit, FY 2023
• Figure 25 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
• Figure 26 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
• Figure 27 : GSK Plc.: Revenue Share, by Country/Region, FY 2023
• Figure 28 : GSK Plc.: Revenue Share, by Business Unit, FY 2023
• Figure 29 : Johnson & Johnson Services Inc.: Revenue Share, by Country/Region, FY 2023
• Figure 30 : Johnson & Johnson Services Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 31 : Medtronic: Revenue Share, by Country/Region, FY 2023
• Figure 32 : Medtronic: Revenue Share, by Business Unit, FY 2023
• Figure 33 : Pfizer Inc.: Revenue Share, by Country/Region, FY 2023
• Figure 34 : Pfizer Inc.: Revenue Share, by Business Unit, FY 2023